期刊文献+

异质性万古霉素耐药金黄葡萄球菌分子流行病学特征

原文传递
导出
摘要 金黄葡萄球菌对万古霉素耐药已成为全世界共同关注的问题。为了解本地区异质性万古霉素耐药金黄葡萄球菌(h-VRSA)的分子遗传学起源,以及与耐甲氧西林金黄葡萄球菌(MRSA)国际流行株之间的关系,我们采用多位点测序分型(multilocus sequence typing,MIST)联合葡萄球菌盒式染色体(staphylococcal cassette chromosome mec,SCCmec)分型对临床标本中筛选出的13株h—VRSA进行分析,报道如下。
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第10期884-885,共2页 Chinese Journal of Microbiology and Immunology
基金 安徽省科技攻关课题(07010302192)
  • 相关文献

参考文献5

  • 1马筱玲,王敬华,李华,陈多炎,濮跃晨.异质性万古霉素耐药葡萄球菌分离及生物学特性观察[J].中华微生物学和免疫学杂志,2004,24(7):583-586. 被引量:48
  • 2Oliveira DC,de Lencastre H.Multiplex PER strategy for rapid identification of structural types and variants of the mec elements in methicillin-resistant S.aureus.Antimicmb Agents Chemother,2002,46(7):2155-2161.
  • 3Enright MC.The evolution of a resistant pathogen-the case of MRSA.Curt opin Pharmacol,2003,3(5):474-479.
  • 4Howe RA,Monk A,Wootton M,et al.Vancomycin susceptibility within methicillin resistant Staphylococcus aureus lineages.Emerg Infect Dis,2004,10(5):855-857.
  • 5Aires de Sousa M,Crisostomo MI,Sanches IS,et al.Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China.J Clin Microbiol,2003,41(1):159-163.

二级参考文献24

  • 1CDC. Staphylococcus aureus resistant to Vancomycin-United States,2002. Morb Mortal Wkly Rep, 2002, 51(26): 565-567.
  • 2CDC. Public Health Dispatch: Vancoomycin-Resistant Staphylococcus aureusPennsylvania, 2002. Morb Mortal Wkly Rep, 2, 2002, 51(40): 902.
  • 3Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother, 1997, 40(1): 135-136.
  • 4Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997, 350(12): 1670-1673.
  • 5Sieradzki K, Villari P, Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of Staphylococci. Antimicrob Agents Chemother, 1998, 42(1):100-107.
  • 6Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in mehthiillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital . J Clin Microbiol, 2000, 38(2): 866-869.
  • 7Poly MC, Grelaud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Stsaphylococcus in a French hospital. Lancet, 1998,351: 1212.
  • 8Viedma DG, Rabadan PM, Diaz M, et al. Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative Staphylococcus isolated from catheters. J Clin Microbiol, 2000, 38(4): 1359-1363.
  • 9Wong SSY, Ho PL, Woo PCY, et al. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis, 1999,29: 760-767.
  • 10CDC. Investigation and Control of Vancomycin-Intermediate and resistant Staphylococcus aureus: A guide for health department and infection control personnel. Atlanta, GA. 2003 (Accessed at http://www. cdc.gov/ncidod/hip/ARESIST/visa-vrsa-guide. pdf)

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部